Daré Bioscience prices $6.0M registered direct offering at $1.37/share

Dare Bioscience, Inc.

Offering of 4,379,581 shares (or pre-funded warrants) at $1.37/share; gross proceeds ~$6.0M.
Concurrent private placement of Series A and B warrants for up to 4,379,581 shares each, exercise price $1.37, subject to stockholder approval.
Closing expected on or about August 17, 2026; Ladenburg Thalmann acting as exclusive placement agent.
Proceeds to fund working capital, 503B compounding, consumer health strategies, R&D, and general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.